SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
46.21
-0.09 (-0.19%)
May 1, 2025, 4:00 PM EDT - Market closed
SpringWorks Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for SpringWorks Therapeutics stock have an average target of 56.86, with a low estimate of 47 and a high estimate of 77. The average target predicts an increase of 23.05% from the current stock price of 46.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SpringWorks Therapeutics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $74 → $47 | Strong Buy → Hold | Downgrades | $74 → $47 | +1.71% | Apr 30, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades $77 → $47 | Strong Buy → Hold | Downgrades | $77 → $47 | +1.71% | Apr 29, 2025 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $66 → $47 | Strong Buy → Hold | Downgrades | $66 → $47 | +1.71% | Apr 29, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $63 → $47 | Buy → Hold | Downgrades | $63 → $47 | +1.71% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +60.14% | Feb 24, 2025 |
Financial Forecast
Revenue This Year
357.05M
from 191.59M
Increased by 86.36%
Revenue Next Year
603.47M
from 357.05M
Increased by 69.02%
EPS This Year
-2.42
from -3.48
EPS Next Year
-0.73
from -2.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 417.5M | 753.1M | 1.2B | ||
| Avg | 357.1M | 603.5M | 865.7M | ||
| Low | 316.5M | 448.8M | 681.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 117.9% | 110.9% | 96.9% | ||
| Avg | 86.4% | 69.0% | 43.5% | ||
| Low | 65.2% | 25.7% | 12.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.93 | 0.19 | 3.86 | ||
| Avg | -2.42 | -0.73 | 1.83 | ||
| Low | -2.75 | -2.00 | -0.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.